ZEISS Launches ALTA DUO 300 to Expand Retinal Imaging Portfolio
Event summary
- ZEISS introduced the ALTA DUO 300, a fully automated, multimodal retinal imaging device combining OCT and fundus photography.
- The device will be showcased at the EURETINA congress in Vienna from October 1–4, 2026, and available in select markets later in 2026.
- ZEISS ALTA DUO 300 integrates four key diagnostic technologies, including AI-enhanced OCT-Angiography and full chamber depth anterior OCT.
- The device complements the existing CIRRUS solution, expanding ZEISS's retinal imaging portfolio to cater to diverse practice needs.
The big picture
ZEISS's launch of the ALTA DUO 300 underscores the growing demand for efficient, multimodal retinal imaging solutions in eye care practices. The device's automated capabilities and integration of multiple diagnostic functionalities position it as a strategic response to the need for streamlined workflows in an increasingly competitive ophthalmology market. With revenue of €2.228 billion in fiscal year 2024/25, ZEISS is leveraging its strong financial position to expand its portfolio and cater to diverse clinical priorities.
What we're watching
- Market Adoption
- The pace at which the ALTA DUO 300 gains traction in eye care practices, particularly smaller ones with varying workflow requirements.
- Competitive Positioning
- Whether ZEISS can sustain its leadership in retinal imaging against competitors with similar multimodal solutions.
- Regulatory Approvals
- The speed of regulatory approvals in key markets, which will determine the device's global availability and revenue impact.
Related topics